Literature DB >> 15331070

Management of nonalcoholic fatty liver disease: weight control.

Iliana Bouneva1, Donald F Kirby.   

Abstract

With obesity reaching epidemic proportions in the United States, it is imperative that hepatologists have an understanding of the medical ramifications and methods of treatment. Evaluation of nonalcoholic fatty liver disease may get the patient into the office,but weight reduction may provide a therapeutic hurdle. This article provides an overview of current obesity treatment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15331070     DOI: 10.1016/j.cld.2004.04.003

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  3 in total

1.  Dietary trans-fatty acid induced NASH is normalized following loss of trans-fatty acids from hepatic lipid pools.

Authors:  Brent A Neuschwander-Tetri; David A Ford; Sahaja Acharya; George Gilkey; Metin Basaranoglu; Laura H Tetri; Elizabeth M Brunt
Journal:  Lipids       Date:  2012-08-26       Impact factor: 1.880

Review 2.  Nonalcoholic fatty liver disease in children living in the obeseogenic society.

Authors:  H Hesham A-Kader
Journal:  World J Pediatr       Date:  2009-11-13       Impact factor: 2.764

3.  Mechanisms and implications of age-related changes in the liver: nonalcoholic Fatty liver disease in the elderly.

Authors:  Lay Gan; Shivakumar Chitturi; Geoffrey C Farrell
Journal:  Curr Gerontol Geriatr Res       Date:  2011-09-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.